Search company, investor...

Predict your next investment

Venture Capital
FINANCE | Asset/Financial Management
sofinnovapartners.com

Investments

407

Portfolio Exits

81

Funds

18

Partners & Customers

2

About Sofinnova Partners

Sofinnova Partners is a European venture capital firm specializing in Life Sciences. The firm focuses on paradigm-shifting technologies alongside visionary entrepreneurs. Sofinnova Partners seeks to invest as a founding and lead investor in start-ups and corporate spin-offs. The company was founded in 1972 and is based in Paris, France.

Headquarters Location

17, rue de Surène

Paris, 75008,

France

+33 (0)1 5305-4100

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Expert Collections containing Sofinnova Partners

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Sofinnova Partners in 1 Expert Collection, including Synthetic Biology.

S

Synthetic Biology

382 items

Latest Sofinnova Partners News

Sofinnova launches AI platform to advance life sciences investment

Dec 6, 2023

2h agoPrivate EquityAlternative InvestmentalternativeswatchViews: 61 Sofinnova Partners launched Sofinnova.AI, an artificial intelligence platform designed to uncover novel insights and boost life sciences innovation. Not a member yet? Free Membership for Qualified Investors and Industry Participants Easily Customize Content to Match Your Investment Preferences Breaking News 24/7/365 Alternative Investment Listings & LeaderBoards Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets,Presentations, Investment Mandates, Video PitchBooks & More! Company Directory AUM Accelerator Program (designed for investment managers) Over 450K+ Industry Headlines, Posts and Updates ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY.CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN.PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.THIS IS NOT A SOLICITATION FOR INVESTMENT.THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY.IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES.ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM.PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT. ALPHAMAVEN

Sofinnova Partners Investments

407 Investments

Sofinnova Partners has made 407 investments. Their latest investment was in T-Therapeutics as part of their Series A on November 11, 2023.

CBI Logo

Sofinnova Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/15/2023

Series A

T-Therapeutics

$59.85M

Yes

1

10/26/2023

Series A

Betteromics

$20M

Yes

2

10/26/2023

Seed VC

L'école AI

$3M

Yes

Preston-Werner Ventures, and Undisclosed Angel Investors

3

10/18/2023

PIPE - II

Subscribe to see more

$99M

Subscribe to see more

10

10/12/2023

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/15/2023

10/26/2023

10/26/2023

10/18/2023

10/12/2023

Round

Series A

Series A

Seed VC

PIPE - II

Seed VC

Company

T-Therapeutics

Betteromics

L'école AI

Subscribe to see more

Subscribe to see more

Amount

$59.85M

$20M

$3M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Preston-Werner Ventures, and Undisclosed Angel Investors

Sources

1

2

3

10

10

Sofinnova Partners Portfolio Exits

81 Portfolio Exits

Sofinnova Partners has 81 portfolio exits. Their latest portfolio exit was LimFlow on November 01, 2023.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

11/1/2023

Acquired

$99M

4

10/17/2023

Acquired

$99M

2

9/15/2023

IPO

$99M

Public

3

8/8/2023

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

7/24/2023

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/1/2023

10/17/2023

9/15/2023

8/8/2023

7/24/2023

Exit

Acquired

Acquired

IPO

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

4

2

3

10

10

Sofinnova Partners Acquisitions

1 Acquisition

Sofinnova Partners acquired 1 company. Their latest acquisition was NovusPharma on September 20, 1999.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

9/20/1999

Convertible Note

$99M

Management Buyout

1

Date

9/20/1999

Investment Stage

Convertible Note

Companies

Valuation

$99M

Total Funding

Note

Management Buyout

Sources

1

Sofinnova Partners Fund History

18 Fund Histories

Sofinnova Partners has 18 funds, including Sofinnova Industrial Biotech II.

Closing Date

Fund

Fund Type

Status

Amount

Sources

11/17/2021

Sofinnova Industrial Biotech II

$169.61M

1

10/19/2021

Sofinnova Capital X

$549.69M

1

7/13/2021

MD Start III

$75M

2

3/3/2021

Sofinnova Crossover Fund

$99M

10

10/17/2019

Sofinnova Capital IX

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

11/17/2021

10/19/2021

7/13/2021

3/3/2021

10/17/2019

Fund

Sofinnova Industrial Biotech II

Sofinnova Capital X

MD Start III

Sofinnova Crossover Fund

Sofinnova Capital IX

Fund Type

Subscribe to see more

Status

Subscribe to see more

Amount

$169.61M

$549.69M

$75M

$99M

$99M

Sources

1

1

2

10

10

Sofinnova Partners Partners & Customers

2 Partners and customers

Sofinnova Partners has 2 strategic partners and customers. Sofinnova Partners recently partnered with Apollo on May 5, 2022.

Date

Type

Business Partner

Country

News Snippet

Sources

5/16/2022

Partner

United States

Sofinnova Partners and Apollo Form Strategic Partnership in Life Sciences

NEW YORK & PARIS -- -- Apollo and Sofinnova Partners , a leading European life sciences venture capital firm based in Paris , London , and Milan , today announced a long-term strategic and financial partnership .

2

2/28/2018

Partner

Italy

Subscribe to see more

Subscribe to see more

10

Date

5/16/2022

2/28/2018

Type

Partner

Partner

Business Partner

Country

United States

Italy

News Snippet

Sofinnova Partners and Apollo Form Strategic Partnership in Life Sciences

NEW YORK & PARIS -- -- Apollo and Sofinnova Partners , a leading European life sciences venture capital firm based in Paris , London , and Milan , today announced a long-term strategic and financial partnership .

Subscribe to see more

Subscribe to see more

Sources

2

10

Sofinnova Partners Team

12 Team Members

Sofinnova Partners has 12 team members, including current Chief Financial Officer, Christophe Blanche.

Name

Work History

Title

Status

Christophe Blanche

Iris Capital, and PwC

Chief Financial Officer

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Christophe Blanche

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Iris Capital, and PwC

Title

Chief Financial Officer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Compare Sofinnova Partners to Competitors

BioCapital Europe Logo
BioCapital Europe

BioCapital Europe is a life sciences investment conference that offers VCs and institutional investors unique and timely access to biotech, medtech, and diagnostics companies from the Benelux and Europe. It is based in Amsterdam, Netherlands.

Sciety Logo
Sciety

Sciety is an investment syndicate that offers capital market services with a focus on life science. It specializes in investment, finance, market analysis, and more. It is based in Stockholm, Sweden.

Sofiouest Logo
Sofiouest

Sofiouest is an investment and holding company that invests in digital innovation, development-transmission capital, and business real estate. Beyond equity investments in companies, Sofiouest invests indirectly in seed or growth funds. It was founded in 1985 and is based in Paris, France.

M
Medilink UK

Medilink UK is a membership-based professional association and consulting firm that focuses on life science company growth. It uses the combined strengths of its regional partners to assist the growth and development of the life sciences commercial, academic, and clinical communities across the UK. It provides services to the medical device, pharmaceutical, and biotechnology industries. It was founded in 2005 and is based in Nottingham, United Kingdom.

S
Syncona Partners

Syncona Partners (LON: SYNC) is an investment company. The company offers services that include founding, building, and funding companies. It makes investments in life sciences companies including gene therapy, cell therapy, biologics, and small molecule fields. The company was founded in 2012 and is based in London, U.K.

Dutch Life Sciences Conference Logo
Dutch Life Sciences Conference

Dutch Life Sciences Conference brings together creative entrepreneurs and expert investors. It is hosted by organisations and companies whose mission is to help realize the further development and growth of the Dutch life sciences industry. It is based in Lisse, The Netherlands.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.